Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

2.

LPA1 is a key mediator of intracellular signalling and neuroprotection triggered by tetracyclic antidepressants in hippocampal neurons.

Olianas MC, Dedoni S, Onali P.

J Neurochem. 2017 Oct;143(2):183-197. doi: 10.1111/jnc.14150. Epub 2017 Sep 11.

PMID:
28815598
3.

The GABAB positive allosteric modulators CGP7930 and GS39783 stimulate ERK1/2 signalling in cells lacking functional GABAB receptors.

Olianas MC, Dedoni S, Onali P.

Eur J Pharmacol. 2017 Jan 5;794:135-146. doi: 10.1016/j.ejphar.2016.11.030. Epub 2016 Nov 19.

PMID:
27876620
4.

LPA1 Mediates Antidepressant-Induced ERK1/2 Signaling and Protection from Oxidative Stress in Glial Cells.

Olianas MC, Dedoni S, Onali P.

J Pharmacol Exp Ther. 2016 Nov;359(2):340-353. Epub 2016 Sep 7.

5.

Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation.

Olianas MC, Dedoni S, Onali P.

Br J Pharmacol. 2016 Oct;173(19):2910-28. doi: 10.1111/bph.13570. Epub 2016 Aug 26.

6.

Interferon-β Inhibits Neurotrophin 3 Signalling and Pro-Survival Activity by Upregulating the Expression of Truncated TrkC-T1 Receptor.

Dedoni S, Olianas MC, Ingianni A, Onali P.

Mol Neurobiol. 2017 Apr;54(3):1825-1843. doi: 10.1007/s12035-016-9789-2. Epub 2016 Feb 18.

PMID:
26887385
7.
8.
9.

Interferon-β counter-regulates its own pro-apoptotic action by activating p38 MAPK signalling in human SH-SY5Y neuroblastoma cells.

Dedoni S, Olianas MC, Onali P.

Apoptosis. 2014 Oct;19(10):1509-26. doi: 10.1007/s10495-014-1024-x.

PMID:
25086905
10.

Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparison with Neupogen®.

Crobu D, Spinetti G, Schrepfer R, Tonon G, Jotti GS, Onali P, Dedoni S, Orsini G, Di Stefano A.

BMC Pharmacol Toxicol. 2014 Feb 21;15:7. doi: 10.1186/2050-6511-15-7.

11.

Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.

Dedoni S, Olianas MC, Ingianni A, Onali P.

Neuropharmacology. 2014 Apr;79:321-34. doi: 10.1016/j.neuropharm.2013.12.002. Epub 2013 Dec 11.

PMID:
24333329
12.

Potentiation of dopamine D1-like receptor signaling by concomitant activation of δ- and μ-opioid receptors in mouse medial prefrontal cortex.

Olianas MC, Dedoni S, Onali P.

Neurochem Int. 2012 Dec;61(8):1404-16. doi: 10.1016/j.neuint.2012.10.005. Epub 2012 Oct 13.

PMID:
23073238
13.

The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors.

Olianas MC, Dedoni S, Onali P.

Br J Pharmacol. 2012 Nov;167(6):1329-41. doi: 10.1111/j.1476-5381.2012.02078.x.

14.

Type I interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons.

Dedoni S, Olianas MC, Ingianni A, Onali P.

J Neurochem. 2012 Jul;122(1):58-71. doi: 10.1111/j.1471-4159.2012.07766.x. Epub 2012 May 21.

15.
16.

Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes.

Selis F, Schrepfer R, Sanna R, Scaramuzza S, Tonon G, Dedoni S, Onali P, Orsini G, Genovese S.

Results Pharma Sci. 2012 Sep 18;2:58-65. doi: 10.1016/j.rinphs.2012.09.001. eCollection 2012.

17.

δ-Opioid receptors stimulate the metabolic sensor AMP-activated protein kinase through coincident signaling with G(q/11)-coupled receptors.

Olianas MC, Dedoni S, Olianas A, Onali P.

Mol Pharmacol. 2012 Feb;81(2):154-65. doi: 10.1124/mol.111.075267. Epub 2011 Oct 26.

18.

Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor.

Olianas MC, Dedoni S, Onali P.

Eur J Pharmacol. 2011 Jun 25;660(2-3):341-50. doi: 10.1016/j.ejphar.2011.04.012. Epub 2011 Apr 19.

PMID:
21515255
19.

Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.

Olianas MC, Dedoni S, Onali P.

Neuropharmacology. 2011 Jun;60(7-8):1326-36. doi: 10.1016/j.neuropharm.2011.01.032. Epub 2011 Jan 27.

PMID:
21276805
20.

δ-Opioid receptors stimulate GLUT1-mediated glucose uptake through Src- and IGF-1 receptor-dependent activation of PI3-kinase signalling in CHO cells.

Olianas MC, Dedoni S, Onali P.

Br J Pharmacol. 2011 Jun;163(3):624-37. doi: 10.1111/j.1476-5381.2011.01234.x.

21.

Interferon-β induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PI3K/Akt pathway.

Dedoni S, Olianas MC, Onali P.

J Neurochem. 2010 Dec;115(6):1421-33. doi: 10.1111/j.1471-4159.2010.07046.x. Epub 2010 Nov 11.

22.

Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes.

Onali P, Dedoni S, Olianas MC.

J Pharmacol Exp Ther. 2010 Jan;332(1):255-65. doi: 10.1124/jpet.109.159939. Epub 2009 Oct 14.

23.

Agonist activity of N-desmethylclozapine at delta-opioid receptors of human frontal cortex.

Olianas MC, Dedoni S, Ambu R, Onali P.

Eur J Pharmacol. 2009 Apr 1;607(1-3):96-101. doi: 10.1016/j.ejphar.2009.02.025. Epub 2009 Feb 23.

PMID:
19239909
24.
26.
27.

Stimulation of cyclic AMP formation and nerve electrical activity by octopamine in the terminal abdominal ganglion of the female gypsy moth Lymantria dispar.

Olianas MC, Solari P, Garau L, Liscia A, Crnjar R, Onali P.

Brain Res. 2006 Feb 3;1071(1):63-74. Epub 2006 Jan 17.

PMID:
16412393
28.

Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.

Olianas MC, Concas D, Onali P.

Br J Pharmacol. 2006 Feb;147(4):360-70.

29.

The pharmacological action of MT-7.

Onali P, Adem A, Karlsson E, Olianas MC.

Life Sci. 2005 Feb 18;76(14):1547-52. Epub 2004 Dec 18. Review.

PMID:
15680165
30.

Allosteric modulation of GABA(B) receptor function in human frontal cortex.

Olianas MC, Ambu R, Garau L, Onali P.

Neurochem Int. 2005 Jan;46(2):149-58.

PMID:
15627515
31.
32.

Action of the muscarinic toxin MT7 on agonist-bound muscarinic M1 receptors.

Olianas MC, Adem A, Karlsson E, Onali P.

Eur J Pharmacol. 2004 Mar 8;487(1-3):65-72.

PMID:
15033377
33.

Positive regulation of GABA(B) receptors dually coupled to cyclic AMP by the allosteric agent CGP7930.

Onali P, Mascia FM, Olianas MC.

Eur J Pharmacol. 2003 Jun 20;471(2):77-84.

PMID:
12818694
35.

Muscarinic M4 receptor inhibition of dopamine D1-like receptor signalling in rat nucleus accumbens.

Onali P, Olianas MC.

Eur J Pharmacol. 2002 Jul 19;448(2-3):105-11.

PMID:
12144929
37.

Evidence of pituitary adenylate cyclase activating polypeptide (PACAP) in pancreatic islet cells by confocal microscopy.

Petruzzo P, Cappai A, Spiga S, Picciau S, Serra G, Fattore L, Onali P, Brotzu G.

Pancreas. 2001 Jul;23(1):68-71.

PMID:
11451150
38.
40.

Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors.

Karlsson E, Jolkkonen M, Mulugeta E, Onali P, Adem A.

Biochimie. 2000 Sep-Oct;82(9-10):793-806. Review.

PMID:
11086210
41.

Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).

Olianas MC, Maullu C, Adem A, Mulugeta E, Karlsson E, Onali P.

Br J Pharmacol. 2000 Oct;131(3):447-52.

44.
45.
46.
47.
48.

Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.

Olianas MC, Ingianni A, Maullu C, Adem A, Karlsson E, Onali P.

J Pharmacol Exp Ther. 1999 Jan;288(1):164-70.

49.

Neurotoxins in neurobiology: from basic research to clinical application.

Clementi F, Dolly OJ, Onali P, Bagetta G.

Toxicon. 1998 Dec;36(12):2043-6. No abstract available.

PMID:
9839689
50.

Identification of rat brain muscarinic M4 receptors coupled to cyclic AMP using the selective antagonist muscarinic toxin 3.

Olianas MC, Adem A, Karlsson E, Onali P.

Eur J Pharmacol. 1998 Sep 18;357(2-3):235-42.

PMID:
9797042

Supplemental Content

Support Center